Pivot Colleges Push Back, Ozempic Price Promise, and White House vs. Anthropic
954 snips
Oct 21, 2025 Kara and Scott dive into the nationwide No Kings protests and the backlash against Trump's college compact. They discuss the implications of Trump's promise to lower Ozempic prices and its effect on GLP-1 stocks. AI regulation takes center stage as David Sacks clashes with Anthropic, while Peter Thiel’s provocative views on AI and religion also spark debate. The duo highlights cybersecurity threats from a recent AWS outage and evaluates the impact of data centers on local communities.
AI Snips
Chapters
Transcript
Episode notes
GLP-1s Could Be The Most Tangible Tech Of 2024
- GLP-1 drugs are likely to have bigger immediate quality-of-life impact than many hyped technologies.
- Both hosts argue broad access could yield major physical, mental, and economic benefits.
Doctors At Dinner Admitted Using GLP-1s
- Scott attended a neuroscientists' dinner where many doctors admitted using GLP-1s themselves.
- He uses this as an adoption signal that the drugs work for medical professionals too.
Accutane Transformed Scott's Teenage Life
- Scott shared how Accutane cleared his severe acne in 11 weeks and changed his confidence.
- He uses the story to analogize the life-changing potential of GLP-1 drugs.